Riskpilot← Back to searchSign inGet full accessLHLS LUNGEFOND STI
STIActiveOrg 997848934Ragnar Strøms veg 10, 2067 JessheimActivities of other membership organisations n.e.c. · NACE 9499Est. 20110 employeeswww.lhl.no
Revenue 2024
NOK 0
EBITDA margin
—
-178% vs 2023
Equity ratio
99.9%
Financial strength
Net profit 2024
NOK -902K
-117% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -2,7M | -178% |
| Net profit | NOK -902K | -117% |
| Total assets | NOK 25,9M | -3% |
| Equity | NOK 25,8M | -3% |
| Employees | 0 | — |
Legal name
LHLS LUNGEFOND STI
Org number
997848934
Legal form
Stiftelse
NACE code
9499 · Activities of other membership organisations n.e.c.
Founded
15. desember 2011
Share capital
—
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Ragnar Strøms veg 10, 2067 Jessheim
Website
www.lhl.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 051 | 688 | 1 273 | 3 471 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 1 019 | 657 | 1 243 | 3 439 | −2 671 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 019 | 657 | 1 243 | 3 439 | −2 671 |
| Net financials | 1 084 | 1 129 | −1 859 | 1 866 | 1 769 |
| Profit before tax | 2 103 | 1 786 | −617 | 5 305 | −902 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 2 103 | 1 786 | −617 | 5 305 | −902 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 20 272 | 22 059 | 21 442 | 26 755 | 25 870 |
| Equity | 20 272 | 22 059 | 21 442 | 26 747 | 25 845 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 9 | 25 |
| Total debt | 0 | 0 | 0 | 9 | 25 |
EBITDA margin
-267104800.0%
This company
15.8%
Market median
-1690536809% vs market
20202024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-3.5%
This company
18.4%
Market median
-119% vs market
20202024
Net profit margin
-90159900.0%
This company
8.1%
Market median
-1113085285% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MW Contact Person | Contact Person | 2025 |
ST Deputy Member | Deputy Member | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Chairman | 2012 – 2024 | |
| Board of Directors | 2012 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LHLS LUNGEFOND STI also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Westby | Contact Person | 0 companies |
| Stig Terje Tolo | Deputy Member | 0 companies |
| Helle Stordrange Grøttum | Board of Directors | 0 companies |
| Frode Jahren | Chairman | 0 companies |
| Mari Larsen | Chairman | 0 companies |
| Simen Brændhaugen | Board of Directors | 0 companies |
| Rune Hagerup | Board of Directors | 0 companies |